North Korea Sanctions — Medical Devices Requiring Specific Authorization

Current understanding

OFAC has published a list of medical devices that are excluded from the general license authorizing exports and reexports to North Korea under the North Korea Sanctions Regulations (31 CFR Part 510). Items on this list require case-by-case specific authorization (a specific license) from OFAC before export or reexport to the DPRK. The action is a final rule administrative implementation and does not create a new sanctions mechanism; exporters of humanitarian medical goods must screen shipments against the excluded list, while consumer price impact is negligible given the narrow bilateral trade flow.

Evidence log

• 2025-11-07 — North Korean Human Rights Reauthorization Act of 2025: cross-connection with north-korean-human-rights-act: Both address the U.S. sanctions and human-rights statutory framework toward North Korea, with the reauthorization act sustaining the broader policy backdrop under which specific trade authorizations (e.g., medical device carve-outs) operate. (novelty: 2)
• 2025-03-04 — Peace on the Korean Peninsula Act: cross-connection with peace-on-korean-peninsula-act: Both concern U.S. posture toward North Korea; a shift toward diplomatic engagement under HR1841 could interact with existing DPRK sanctions licensing regimes such as medical device authorizations. (novelty: 2)

Open questions

Related